Literature DB >> 19066402

Lipid phosphate phosphatases and signaling.

David N Brindley1, Carlos Pilquil.   

Abstract

Lipid phosphate phosphatases (LPPs) regulate cell signaling by modifying the concentrations of lipid phosphates versus their dephosphorylated products. The ecto-activity regulates the availability of extracellular lysophosphatidate (LPA) and sphingosine 1-phosphate (S1P) and thereby signaling by their respective receptors. LPP products (monoacylglycerol or sphingosine) are taken up by cells and rephosphorylated to produce LPA and S1P, respectively, which activate intracellular signaling cascades. The proposed integrin binding domain on the external surface of LPP3 modifies cell/cell interactions. Expression of LPPs on internal membranes controls signaling depending on the access of lipid phosphates to their active sites. Different LPPs perform distinct functions, probably based on integrin binding, their locations, and their abilities to metabolize different lipid phosphates in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066402      PMCID: PMC2674702          DOI: 10.1194/jlr.R800055-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  48 in total

1.  Mice mutant for Ppap2c, a homolog of the germ cell migration regulator wunen, are viable and fertile.

Authors:  N Zhang; J P Sundberg; T Gridley
Journal:  Genesis       Date:  2000-08       Impact factor: 2.487

Review 2.  Mammalian lipid phosphate phosphohydrolases.

Authors:  D N Brindley; D W Waggoner
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

3.  Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Authors:  Laurens A van Meeteren; Paula Ruurs; Evangelos Christodoulou; James W Goding; Hideo Takakusa; Kazuya Kikuchi; Anastassis Perrakis; Tetsuo Nagano; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2005-03-15       Impact factor: 5.157

4.  The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate.

Authors:  Benjamin J Pettus; Kazuyuki Kitatani; Charles E Chalfant; Tarek A Taha; Toshihiko Kawamori; Jacek Bielawski; Lina M Obeid; Yusuf A Hannun
Journal:  Mol Pharmacol       Date:  2005-05-17       Impact factor: 4.436

5.  Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level.

Authors:  Junming Yue; Kazuaki Yokoyama; Louisa Balazs; Daniel L Baker; David Smalley; Carlos Pilquil; David N Brindley; Gabor Tigyi
Journal:  Cell Signal       Date:  2004-03       Impact factor: 4.315

6.  Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo.

Authors:  Jose L Tomsig; Ashley H Snyder; Evgeny V Berdyshev; Anastasia Skobeleva; Chifundo Mataya; Viswanathan Natarajan; David N Brindley; Kevin R Lynch
Journal:  Biochem J       Date:  2009-05-01       Impact factor: 3.857

7.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

8.  S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake.

Authors:  Ulrike Peest; Sven-Christian Sensken; Paul Andréani; Petra Hänel; Paul P Van Veldhoven; Markus H Gräler
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

9.  Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand.

Authors:  Joseph O Humtsoe; Rodney A Bowling; Shu Feng; Kishore K Wary
Journal:  Biochem Biophys Res Commun       Date:  2005-09-30       Impact factor: 3.575

10.  A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells.

Authors:  Meryem Bektas; Shawn G Payne; Hong Liu; Sravan Goparaju; Sheldon Milstien; Sarah Spiegel
Journal:  J Cell Biol       Date:  2005-06-06       Impact factor: 10.539

View more
  99 in total

Review 1.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  A facile stable-isotope dilution method for determination of sphingosine phosphate lyase activity.

Authors:  Jung H Suh; Abeer Eltanawy; Apoorva Rangan; Julie D Saba
Journal:  Chem Phys Lipids       Date:  2015-09-25       Impact factor: 3.329

3.  Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.

Authors:  Mohamad Navab; Arnab Chattopadhyay; Greg Hough; David Meriwether; Spencer I Fogelman; Alan C Wagner; Victor Grijalva; Feng Su; G M Anantharamaiah; Lin H Hwang; Kym F Faull; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2015-02-02       Impact factor: 5.922

Review 4.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

5.  Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowth.

Authors:  Katrina M Waters; Jon M Jacobs; Marina A Gritsenko; Norman J Karin
Journal:  Bone       Date:  2011-02-26       Impact factor: 4.398

6.  DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease.

Authors:  Ghada Mkannez; Valérie Gagné-Ouellet; Mohamed Jalloul Nsaibia; Marie-Chloé Boulanger; Mickael Rosa; Deborah Argaud; Fayez Hadji; Nathalie Gaudreault; Gabrielle Rhéaume; Luigi Bouchard; Yohan Bossé; Patrick Mathieu
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

7.  Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.

Authors:  Ngoc H On; Sanjot Savant; Myron Toews; Donald W Miller
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

8.  Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.

Authors:  Zahia Touat-Hamici; Henri Weidmann; Yuna Blum; Carole Proust; Hervé Durand; Francesca Iannacci; Veronica Codoni; Pauline Gaignard; Patrice Thérond; Mete Civelek; Sonia A Karabina; Aldons J Lusis; François Cambien; Ewa Ninio
Journal:  Cardiovasc Res       Date:  2016-09-30       Impact factor: 10.787

9.  Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo.

Authors:  Jose L Tomsig; Ashley H Snyder; Evgeny V Berdyshev; Anastasia Skobeleva; Chifundo Mataya; Viswanathan Natarajan; David N Brindley; Kevin R Lynch
Journal:  Biochem J       Date:  2009-05-01       Impact factor: 3.857

Review 10.  Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.

Authors:  Viswanathan Natarajan; Steven M Dudek; Jeffrey R Jacobson; Liliana Moreno-Vinasco; Long Shuang Huang; Taimur Abassi; Biji Mathew; Yutong Zhao; Lichun Wang; Robert Bittman; Ralph Weichselbaum; Evgeny Berdyshev; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.